Blacktrace announces agreement to sell Syrris and Glass Solutions business to Asahi Glassplant
Blacktrace Holdings Limited (Blacktrace), a private company focused on designing, developing and manufacturing cutting-edge scientific products, announced the signing of a definitive agreement to sell the Syrris and Glass Solutions portfolios to
Asahi Glassplant UK Limited (AG! UK) on 1st January 2020.
Mark Gilligan, Chairman of the Board of Directors and Chief Executive Officer, said: “Blacktrace has been spectacularly successful at innovating and developing cutting edge scientific products which are sold globally via dedicated brands. Syrris and Glass Solutions are examples of our success within the chemistry sector, but the saturation led us to explore partners to scale the commercial exploitation. Asahi Glassplant Inc. has proven to be the most suitable partner who could do these products justice and take them forwards with focus. There is a wonderful synergy between Syrris and AG!, and I have full confidence that Syrris will continue to grow at an exciting rate.”
Yasu Ikeda, CEO of Asahi Glassplant Inc., commented: “We are delighted to have successfully completed this acquisition. This allows us to increase our global support of our customers, while also increasing our manufacturing capacity. We have been working closely with Syrris for many years and we are very excited to now include the Syrris systems in our portfolio. Syrris systems have continually demonstrated to be the most easy-to-use, flexible and powerful batch reactor and flow chemistry systems in the world.”
Blacktrace will continue to own the Dolomite Microfluidics, Dolomite Bio and Particle Works brand portfolios, which consist of leading brands in the biotechnology, pharmaceutical and particle engineering industry fields. As an industry leader in microfluidics Blacktrace is dedicated to leading the way with a wide variety of innovative products in single cell research and microfluidic applications.
Mark continued: “Moving forwards we are looking to energetically exploit the Dolomite Microfluidics, Dolomite Bio and Particle Works brands by developing new technologies and explore whether they can be commercially exploited into new designated brands or ventures. Ultimately Blacktrace at its core is an innovation engine!”
For more information on this topic, please email us at email@example.com